68 participants
A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-03
- Start Date:
- 2025-10-21
- Completion:
- 2028-06-30
Conditions
- Rheumatoid Arthritis
Interventions
- BIOLOGICAL
No Results Yet